866-997-4948(US-Canada Toll Free)

EMEA (Europe, Middle East and Africa) Therapeutic Nuclear Medicines Market Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Therapeutic Area

No. of Pages : 105 Pages

In this report, the EMEA Therapeutic Nuclear Medicines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Therapeutic Nuclear Medicines for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Therapeutic Nuclear Medicines market competition by top manufacturers/players, with Therapeutic Nuclear Medicines sales volume (MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
Cardinal Health
Mallkrodt Plc
GE Healthcare
Lantheus Medical Imaging
Bayer AG
Bracco Imaging SpA
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications SA
IBA Molecular Imaging

On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into
Beta Emitters Therapeutic Nuclear Medicines
Alpha Emitters Therapeutic Nuclear Medicines
Brachytherapy Therapeutic Nuclear Medicines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (MT), market share and growth rate of Therapeutic Nuclear Medicines for each application, including
Hospitals
Ambulatory Surgical Centers
Other
 

Table of Contents

EMEA (Europe, Middle East and Africa) Therapeutic Nuclear Medicines Market Report 2017
1 Therapeutic Nuclear Medicines Overview
1.1 Product Overview and Scope of Therapeutic Nuclear Medicines
1.2 Classification of Therapeutic Nuclear Medicines
1.2.1 EMEA Therapeutic Nuclear Medicines Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Therapeutic Nuclear Medicines Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Beta Emitters Therapeutic Nuclear Medicines
1.2.4 Alpha Emitters Therapeutic Nuclear Medicines
1.2.5 Brachytherapy Therapeutic Nuclear Medicines
1.3 EMEA Therapeutic Nuclear Medicines Market by Application/End Users
1.3.1 EMEA Therapeutic Nuclear Medicines Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Other
1.4 EMEA Therapeutic Nuclear Medicines Market by Region
1.4.1 EMEA Therapeutic Nuclear Medicines Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Therapeutic Nuclear Medicines (2012-2022)
1.5.1 EMEA Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2022)
1.5.2 EMEA Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2022)

2 EMEA Therapeutic Nuclear Medicines Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Therapeutic Nuclear Medicines Market Competition by Players/Manufacturers
2.1.1 EMEA Therapeutic Nuclear Medicines Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Therapeutic Nuclear Medicines Revenue and Share by Players (2012-2017)
2.1.3 EMEA Therapeutic Nuclear Medicines Sale Price by Players (2012-2017)
2.2 EMEA Therapeutic Nuclear Medicines (Volume and Value) by Type/Product Category
2.2.1 EMEA Therapeutic Nuclear Medicines Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Therapeutic Nuclear Medicines Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Therapeutic Nuclear Medicines Sale Price by Type (2012-2017)
2.3 EMEA Therapeutic Nuclear Medicines (Volume) by Application
2.4 EMEA Therapeutic Nuclear Medicines (Volume and Value) by Region
2.4.1 EMEA Therapeutic Nuclear Medicines Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Therapeutic Nuclear Medicines Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Therapeutic Nuclear Medicines Sales Price by Region (2012-2017)

3 Europe Therapeutic Nuclear Medicines (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Therapeutic Nuclear Medicines Sales and Value (2012-2017)
3.1.1 Europe Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
3.2 Europe Therapeutic Nuclear Medicines Sales and Market Share by Type
3.3 Europe Therapeutic Nuclear Medicines Sales and Market Share by Application
3.4 Europe Therapeutic Nuclear Medicines Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Therapeutic Nuclear Medicines Sales Volume by Countries (2012-2017)
3.4.2 Europe Therapeutic Nuclear Medicines Revenue by Countries (2012-2017)
3.4.3 Germany Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
3.4.4 France Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
3.4.5 UK Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
3.4.6 Russia Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
3.4.7 Italy Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
3.4.8 Benelux Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)

4 Middle East Therapeutic Nuclear Medicines (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Therapeutic Nuclear Medicines Sales and Value (2012-2017)
4.1.1 Middle East Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
4.2 Middle East Therapeutic Nuclear Medicines Sales and Market Share by Type
4.3 Middle East Therapeutic Nuclear Medicines Sales and Market Share by Application
4.4 Middle East Therapeutic Nuclear Medicines Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Therapeutic Nuclear Medicines Sales Volume by Countries (2012-2017)
4.4.2 Middle East Therapeutic Nuclear Medicines Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
4.4.4 Israel Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
4.4.5 UAE Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
4.4.6 Iran Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)

5 Africa Therapeutic Nuclear Medicines (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Therapeutic Nuclear Medicines Sales and Value (2012-2017)
5.1.1 Africa Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
5.2 Africa Therapeutic Nuclear Medicines Sales and Market Share by Type
5.3 Africa Therapeutic Nuclear Medicines Sales and Market Share by Application
5.4 Africa Therapeutic Nuclear Medicines Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Therapeutic Nuclear Medicines Sales Volume by Countries (2012-2017)
5.4.2 Africa Therapeutic Nuclear Medicines Revenue by Countries (2012-2017)
5.4.3 South Africa Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
5.4.5 Egypt Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)
5.4.6 Algeria Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017)

6 EMEA Therapeutic Nuclear Medicines Manufacturers/Players Profiles and Sales Data
6.1 Cardinal Health
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Therapeutic Nuclear Medicines Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Cardinal Health Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Mallkrodt Plc
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Therapeutic Nuclear Medicines Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Mallkrodt Plc Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 GE Healthcare
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Therapeutic Nuclear Medicines Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 GE Healthcare Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Lantheus Medical Imaging
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Therapeutic Nuclear Medicines Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Bayer AG
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Therapeutic Nuclear Medicines Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Bayer AG Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Bracco Imaging SpA
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Therapeutic Nuclear Medicines Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Bracco Imaging SpA Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Eczacibasi-Monrol Nuclear Products
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Therapeutic Nuclear Medicines Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Nordion
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Therapeutic Nuclear Medicines Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Nordion Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Advanced Accelerator Applications SA
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Therapeutic Nuclear Medicines Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 IBA Molecular Imaging
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Therapeutic Nuclear Medicines Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 IBA Molecular Imaging Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Therapeutic Nuclear Medicines Manufacturing Cost Analysis
7.1 Therapeutic Nuclear Medicines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Therapeutic Nuclear Medicines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Therapeutic Nuclear Medicines Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Therapeutic Nuclear Medicines Market Forecast (2017-2022)
11.1 EMEA Therapeutic Nuclear Medicines Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Therapeutic Nuclear Medicines Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Therapeutic Nuclear Medicines Price and Trend Forecast (2017-2022)
11.2 EMEA Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Therapeutic Nuclear Medicines Sales Forecast by Type (2017-2022)
11.7 EMEA Therapeutic Nuclear Medicines Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

 

List of Table

List of Tables and Figures

Figure Product Picture of Therapeutic Nuclear Medicines
Figure EMEA Therapeutic Nuclear Medicines Sales Volume (MT) by Type (2012-2022)
Figure EMEA Therapeutic Nuclear Medicines Sales Volume Market Share by Type (Product Category) in 2016
Figure Beta Emitters Therapeutic Nuclear Medicines Product Picture
Figure Alpha Emitters Therapeutic Nuclear Medicines Product Picture
Figure Brachytherapy Therapeutic Nuclear Medicines Product Picture
Figure EMEA Therapeutic Nuclear Medicines Sales Volume (MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Therapeutic Nuclear Medicines by Application in 2016
Figure Hospitals Examples
Figure Ambulatory Surgical Centers Examples
Figure Other Examples
Figure EMEA Therapeutic Nuclear Medicines Market Size (Million USD) by Region (2012-2022)
Figure Europe Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Therapeutic Nuclear Medicines Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Therapeutic Nuclear Medicines Revenue (Million USD) Status and Forecast by Countries
Figure Africa Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Therapeutic Nuclear Medicines Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2012-2022)
Figure EMEA Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Therapeutic Nuclear Medicines Market Major Players Product Sales Volume (MT) (2012-2017)
Table EMEA Therapeutic Nuclear Medicines Sales Volume (MT) of Major Players (2012-2017)
Table EMEA Therapeutic Nuclear Medicines Sales Share by Players (2012-2017)
Figure 2016 Therapeutic Nuclear Medicines Sales Share by Players
Figure 2017 Therapeutic Nuclear Medicines Sales Share by Players
Figure EMEA Therapeutic Nuclear Medicines Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Therapeutic Nuclear Medicines Revenue (Million USD) by Players (2012-2017)
Table EMEA Therapeutic Nuclear Medicines Revenue Share by Players (2012-2017)
Table 2016 EMEA Therapeutic Nuclear Medicines Revenue Share by Players
Table 2017 EMEA Therapeutic Nuclear Medicines Revenue Share by Players
Table EMEA Therapeutic Nuclear Medicines Sale Price (USD/MT) by Players (2012-2017)
Table EMEA Therapeutic Nuclear Medicines Sales (MT) and Market Share by Type (2012-2017)
Table EMEA Therapeutic Nuclear Medicines Sales Share by Type (2012-2017)
Figure Sales Market Share of Therapeutic Nuclear Medicines by Type (2012-2017)
Figure EMEA Therapeutic Nuclear Medicines Sales Market Share by Type (2012-2017)
Table EMEA Therapeutic Nuclear Medicines Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Therapeutic Nuclear Medicines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Therapeutic Nuclear Medicines by Type in 2016
Table EMEA Therapeutic Nuclear Medicines Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Therapeutic Nuclear Medicines Sales (MT) and Market Share by Application (2012-2017)
Table EMEA Therapeutic Nuclear Medicines Sales Share by Application (2012-2017)
Figure Sales Market Share of Therapeutic Nuclear Medicines by Application (2012-2017)
Figure EMEA Therapeutic Nuclear Medicines Sales Market Share by Application in 2016
Table EMEA Therapeutic Nuclear Medicines Sales (MT) and Market Share by Region (2012-2017)
Table EMEA Therapeutic Nuclear Medicines Sales Share by Region (2012-2017)
Figure Sales Market Share of Therapeutic Nuclear Medicines by Region (2012-2017)
Figure EMEA Therapeutic Nuclear Medicines Sales Market Share in 2016
Table EMEA Therapeutic Nuclear Medicines Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Therapeutic Nuclear Medicines Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Therapeutic Nuclear Medicines by Region (2012-2017)
Figure EMEA Therapeutic Nuclear Medicines Revenue Market Share Regions in 2016
Table EMEA Therapeutic Nuclear Medicines Sales Price (USD/MT) by Region (2012-2017)
Figure Europe Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Europe Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017)
Table Europe Therapeutic Nuclear Medicines Sales (MT) by Type (2012-2017)
Table Europe Therapeutic Nuclear Medicines Market Share by Type (2012-2017)
Figure Europe Therapeutic Nuclear Medicines Market Share by Type in 2016
Table Europe Therapeutic Nuclear Medicines Sales (MT) by Application (2012-2017)
Table Europe Therapeutic Nuclear Medicines Market Share by Application (2012-2017)
Figure Europe Therapeutic Nuclear Medicines Market Share by Application in 2016
Table Europe Therapeutic Nuclear Medicines Sales (MT) by Countries (2012-2017)
Table Europe Therapeutic Nuclear Medicines Sales Market Share by Countries (2012-2017)
Figure Europe Therapeutic Nuclear Medicines Sales Market Share by Countries (2012-2017)
Figure Europe Therapeutic Nuclear Medicines Sales Market Share by Countries in 2016
Table Europe Therapeutic Nuclear Medicines Revenue (Million USD) by Countries (2012-2017)
Table Europe Therapeutic Nuclear Medicines Revenue Market Share by Countries (2012-2017)
Figure Europe Therapeutic Nuclear Medicines Revenue Market Share by Countries (2012-2017)
Figure Europe Therapeutic Nuclear Medicines Revenue Market Share by Countries in 2016
Figure Germany Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure France Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure UK Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Russia Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Italy Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Benelux Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Therapeutic Nuclear Medicines Sales (MT) by Type (2012-2017)
Table Middle East Therapeutic Nuclear Medicines Market Share by Type (2012-2017)
Figure Middle East Therapeutic Nuclear Medicines Market Share by Type (2012-2017)
Table Middle East Therapeutic Nuclear Medicines Sales (MT) by Applications (2012-2017)
Table Middle East Therapeutic Nuclear Medicines Market Share by Applications (2012-2017)
Figure Middle East Therapeutic Nuclear Medicines Sales Market Share by Application in 2016
Table Middle East Therapeutic Nuclear Medicines Sales Volume (MT) by Countries (2012-2017)
Table Middle East Therapeutic Nuclear Medicines Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Therapeutic Nuclear Medicines Sales Volume Market Share by Countries in 2016
Table Middle East Therapeutic Nuclear Medicines Revenue (Million USD) by Countries (2012-2017)
Table Middle East Therapeutic Nuclear Medicines Revenue Market Share by Countries (2012-2017)
Figure Middle East Therapeutic Nuclear Medicines Revenue Market Share by Countries (2012-2017)
Figure Middle East Therapeutic Nuclear Medicines Revenue Market Share by Countries in 2016
Figure Saudi Arabia Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Israel Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure UAE Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Iran Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Africa Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Africa Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Therapeutic Nuclear Medicines Sales (MT) by Type (2012-2017)
Table Africa Therapeutic Nuclear Medicines Sales Market Share by Type (2012-2017)
Figure Africa Therapeutic Nuclear Medicines Sales Market Share by Type (2012-2017)
Figure Africa Therapeutic Nuclear Medicines Sales Market Share by Type in 2016
Table Africa Therapeutic Nuclear Medicines Sales (MT) by Application (2012-2017)
Table Africa Therapeutic Nuclear Medicines Sales Market Share by Application (2012-2017)
Figure Africa Therapeutic Nuclear Medicines Sales Market Share by Application (2012-2017)
Table Africa Therapeutic Nuclear Medicines Sales Volume (MT) by Countries (2012-2017)
Table Africa Therapeutic Nuclear Medicines Sales Market Share by Countries (2012-2017)
Figure Africa Therapeutic Nuclear Medicines Sales Market Share by Countries (2012-2017)
Figure Africa Therapeutic Nuclear Medicines Sales Market Share by Countries in 2016
Table Africa Therapeutic Nuclear Medicines Revenue (Million USD) by Countries (2012-2017)
Table Africa Therapeutic Nuclear Medicines Revenue Market Share by Countries (2012-2017)
Figure Africa Therapeutic Nuclear Medicines Revenue Market Share by Countries (2012-2017)
Figure Africa Therapeutic Nuclear Medicines Revenue Market Share by Countries in 2016
Figure South Africa Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Nigeria Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Egypt Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Algeria Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Table Cardinal Health Therapeutic Nuclear Medicines Basic Information List
Table Cardinal Health Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Cardinal Health Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Cardinal Health Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017)
Figure Cardinal Health Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017)
Table Mallkrodt Plc Therapeutic Nuclear Medicines Basic Information List
Table Mallkrodt Plc Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Mallkrodt Plc Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Mallkrodt Plc Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017)
Figure Mallkrodt Plc Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017)
Table GE Healthcare Therapeutic Nuclear Medicines Basic Information List
Table GE Healthcare Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GE Healthcare Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure GE Healthcare Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017)
Figure GE Healthcare Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017)
Table Lantheus Medical Imaging Therapeutic Nuclear Medicines Basic Information List
Table Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017)
Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017)
Table Bayer AG Therapeutic Nuclear Medicines Basic Information List
Table Bayer AG Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bayer AG Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Bayer AG Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017)
Figure Bayer AG Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017)
Table Bracco Imaging SpA Therapeutic Nuclear Medicines Basic Information List
Table Bracco Imaging SpA Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bracco Imaging SpA Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Bracco Imaging SpA Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017)
Figure Bracco Imaging SpA Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017)
Table Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Basic Information List
Table Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017)
Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017)
Table Nordion Therapeutic Nuclear Medicines Basic Information List
Table Nordion Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Nordion Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Nordion Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017)
Figure Nordion Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017)
Table Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Basic Information List
Table Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017)
Figure Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017)
Table IBA Molecular Imaging Therapeutic Nuclear Medicines Basic Information List
Table IBA Molecular Imaging Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017)
Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017)
Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Therapeutic Nuclear Medicines
Figure Manufacturing Process Analysis of Therapeutic Nuclear Medicines
Figure Therapeutic Nuclear Medicines Industrial Chain Analysis
Table Raw Materials Sources of Therapeutic Nuclear Medicines Major Manufacturers in 2016
Table Major Buyers of Therapeutic Nuclear Medicines
Table Distributors/Traders List
Figure EMEA Therapeutic Nuclear Medicines Sales (MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Therapeutic Nuclear Medicines Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA Therapeutic Nuclear Medicines Sales (MT) Forecast by Region (2017-2022)
Figure EMEA Therapeutic Nuclear Medicines Sales Market Share Forecast by Region (2017-2022)
Table EMEA Therapeutic Nuclear Medicines Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Therapeutic Nuclear Medicines Revenue Market Share Forecast by Region (2017-2022)
Table Europe Therapeutic Nuclear Medicines Sales (MT) Forecast by Countries (2017-2022)
Figure Europe Therapeutic Nuclear Medicines Sales Market Share Forecast by Countries (2017-2022)
Table Europe Therapeutic Nuclear Medicines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Therapeutic Nuclear Medicines Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Therapeutic Nuclear Medicines Sales (MT) Forecast by Countries (2017-2022)
Figure Middle East Therapeutic Nuclear Medicines Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Therapeutic Nuclear Medicines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Therapeutic Nuclear Medicines Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Therapeutic Nuclear Medicines Sales (MT) Forecast by Countries (2017-2022)
Figure Africa Therapeutic Nuclear Medicines Sales Market Share Forecast by Countries (2017-2022)
Table Africa Therapeutic Nuclear Medicines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Therapeutic Nuclear Medicines Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Therapeutic Nuclear Medicines Sales (MT) Forecast by Type (2017-2022)
Figure EMEA Therapeutic Nuclear Medicines Sales Market Share Forecast by Type (2017-2022)
Table EMEA Therapeutic Nuclear Medicines Sales (MT) Forecast by Application (2017-2022)
Figure EMEA Therapeutic Nuclear Medicines Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
 

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *